ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,361 | -11.6% | 19,679 | +21.2% | 0.00% | – |
| Q2 2023 | $58,133 | +47.8% | 16,239 | -10.1% | 0.00% | – |
| Q1 2023 | $39,332 | -85.4% | 18,056 | -19.6% | 0.00% | -100.0% |
| Q4 2022 | $270,000 | +67.7% | 22,459 | -9.1% | 0.00% | – |
| Q3 2022 | $161,000 | +83.0% | 24,701 | +28.6% | 0.00% | – |
| Q2 2022 | $88,000 | -35.8% | 19,203 | +17.4% | 0.00% | – |
| Q1 2022 | $137,000 | -63.5% | 16,354 | -37.7% | 0.00% | -100.0% |
| Q4 2021 | $375,000 | -2.8% | 26,267 | +49.5% | 0.00% | 0.0% |
| Q3 2021 | $386,000 | +282.2% | 17,570 | +131.5% | 0.00% | – |
| Q2 2021 | $101,000 | +110.4% | 7,588 | +60.6% | 0.00% | – |
| Q1 2021 | $48,000 | +1100.0% | 4,725 | +372.5% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,355,925 | $2,955,917 | 2.56% |
| Susquehanna International Group Ltd. | 113,526 | $247,487 | 0.14% |
| XTX Topco Ltd | 151,620 | $330,532 | 0.07% |
| Corsair Capital Management | 47,256 | $103,018 | 0.04% |
| Diametric Capital, LP | 14,314 | $31,205 | 0.02% |
| Draper Asset Management, LLC | 5,320 | $11,598 | 0.02% |
| ETF MANAGERS GROUP, LLC | 68,940 | $150,289 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $12,267 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 506,255 | $1,103,636 | 0.00% |
| Apollon Wealth Management, LLC | 20,000 | $43,600 | 0.00% |